Honokiol Inhibits Epidermal Growth Factor Receptor Signaling and Enhances the Antitumor Effects of Epidermal Growth Factor Receptor Inhibitors - Concepedia

Concepedia

Publication | Open Access

Honokiol Inhibits Epidermal Growth Factor Receptor Signaling and Enhances the Antitumor Effects of Epidermal Growth Factor Receptor Inhibitors

DOI Full Paper Access

111

Citations

44

References

2010

Year

Rebecca J. Leeman‐Neill, Quan-Ying Cai, Sonali Joyce, Sufi M. Thomas, Neil E. Bhola, Daniel B. Neill, Jack L. Arbiser, Jennifer R. Grandis

Clinical Cancer Research

Abstract

These results suggest that honokiol may be an effective therapeutic agent in HNSCC, in which it can augment the effects of EGFR inhibitors and overcome drug resistance.

References

	Year	Citations

Page 1